Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

gatifloxacin Clinical Trials

« Back to Dashboard
First 100 trials shown — repeat this search at ClinicalTrials.gov

Title Status Condition Last Changed FDA link
Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of Subjects Completed Cataract Extraction December 7, 2011 NCT00824070
Concentration of Besifloxacin, Gatifloxacin, and Moxifloxacin in Human Conjunctiva After Topical Instillation Completed Healthy December 7, 2011 NCT00905762
One Hour Preoperative Gatifloxacin Completed Ophthalmic Surgery January 26, 2015 NCT00350363
Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis Completed TB Multi-drug Resistant June 9, 2011 NCT00396084
Non-Inferiority of Gatifloxacin/Prednisolone Association vs Isolated Administration in Prevention of Ocular Infection/Inflammation Completed Infection and Inflammation After Refractive Surgery (Lasik). October 14, 2010 NCT01218737
Gatifloxacin Versus Ceftriaxone in the Treatment of Enteric Fever Active, not recruiting Enteric Fever; Typhoid Fever November 26, 2014 NCT01421693
Effect of Moxifloxacin Versus Gatifloxacin on Corneal Epithelium Following Pterygium Excision Not yet recruiting Primary Pterygium May 4, 2009 NCT00892918
Besifloxacin Ophthalmic Suspension Verses Gatifloxacin Ophthalmic Solution in Neonates With Bacterial Conjunctivitis Terminated Bacterial Conjunctivitis September 2, 2014 NCT01330355
Preoperative Topical Gatifloxacin on Anterior Chamber Cultures After Cataract Surgery Suspended Endophthalmitis May 17, 2007 NCT00335231
Effectiveness Study of Zymar Versus Vigamox for Preoperative Sterilization of the Ocular Surface After Loading Dose Active, not recruiting Eye Infection; Infection July 3, 2006 NCT00347828
A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis Completed Bacterial Conjunctivitis October 24, 2011 NCT00518089
A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis Completed Bacterial Conjunctivitis October 24, 2011 NCT00509873
Effect of Topical Fluoroquinolones on Epithelial Wound Healing After PRK Completed Corneal Epithelial Wound Healing December 7, 2007 NCT00569881
Comparison of the Effect of 4th Generation Fluoroquinolones, Gatifloxacin and Moxifloxacin, on Epithelial Healing Following Photorefractive Keratectomy (PRK), A Substudy of: Initial Evaluation of Excimer Laser Keratorefractive Surgery in U.S. Army Personnel (WU # 2335-99) Completed Epithelium, Corneal June 26, 2013 NCT00414011
Safety and Efficacy Study of Gatifloxacin Compared With Ciprofloxacin in Patients With Acute Bacterial Corneal Ulcers Completed Acute Bacterial Corneal Ulcers; Bacterial Keratitis July 25, 2008 NCT00651586
Prospective Randomized Comparison of Zymar(Gatifloxacin) and Vigamox (Moxifloxacin) in Killing Conjunctival Bacterial Flora Following a One-hour Application Withdrawn Conjunctical Flora June 12, 2013 NCT00466570
A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis Completed Bacterial Conjunctivitis August 17, 2011 NCT00464438
A Comparison of Three Fluoroquinolone Topical Eyedrops in the Treatment of Infectious Corneal Ulcers. Terminated Corneal Ulcers August 11, 2015 NCT01928693
A Clinical Study to Evaluate if Benzalkonium Chloride (BAK) in a Quinolone Eyedrop Reduces the Likelihood of Developing Resistant Organisms Completed Anti-biotic Resistance November 16, 2011 NCT00874887
A Controlled Trial of a 4-Month Quinolone-Containing Regimen for the Treatment of Pulmonary Tuberculosis Recruiting Tuberculosis September 20, 2005 NCT00216385
Swiss PACK-CXL Multicenter Trial for the Treatment of Infectious Keratitis Recruiting Keratitis; Infectious Disease (Manifestation) March 23, 2016 NCT02717871
Ocular Availability in Human Tears After Topical Administration of 1.5% Levofloxacin Compared to Active Comparators Completed Healthy February 4, 2009 NCT00703313
Topical Antibiotics and Intravitreous Injections Completed Intravitreous; Injections May 13, 2014 NCT00410891
Pravastatin or Atorvastatin Evaluation and Infection Therapy (TIMI22) Completed Actue Coronary Syndromes April 7, 2011 NCT00382460
Patients Response to Early Switch To Oral:Osteomyelitis Study Not yet recruiting Osteomyelitis March 27, 2014 NCT02099240
An Observational Study of Oral Fluoroquinolones and the Risk of Retinal Detachment Completed Retinal Detachment June 18, 2013 NCT01881438
Therapeutic Variables in Cataract Surgery Completed Cataract Surgery August 17, 2007 NCT00407017
Efficacy of Topical Ketorolac Versus Placebo for Improving Visual Outcomes Following Multifocal IOL Implantation Completed Macula Thickening September 5, 2007 NCT00433225
Research of the Application of Triple Antibiotic Paste in Primary Teeth With Pericpical Periodontitis Active, not recruiting Periapical Diseases July 21, 2014 NCT02196740
Intraocular Steroid After Cataract Surgery Study Completed Cataract May 24, 2007 NCT00478764
Proparacaine vs Placebo for Corneal Injuries Completed Corneal Abrasions February 21, 2008 NCT00620997
Antibiotic Resistant Patterns of Conjunctival and Nasophayngeal Flora After Repeated Exposure to Topical Antibiotics Completed Age-related Macular Degeneration December 7, 2015 NCT00831961
Surveillance of Ocular Surface Flora (SURFACE) Completed Cataract July 16, 2012 NCT00621933

Source: ClinicalTrials.gov

This preview shows a limited data set. Complete access is available with a Subscription

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.